Clinical Trials Logo

Clinical Trial Summary

Multicenter, randomized, controlled, open-label trial to assess if semiquantitative multiplex PCR assay, as compared to conventional microbiology, can reduce the percentage of patients without microbiological diagnosis in the first 24 hours from HAP/VAP suspicion, thus allowing early de-escalation.


Clinical Trial Description

Hospital-acquired pneumonia and ventilator-associated pneumonia are leading cause of morbidity and mortality in Intensive Care Unit due to the underlining clinical conditions of critically ill patients and the high rate of multidrug resistance among causative agents. In patients with sepsis and septic shock, early and appropriate antibiotics are essential for improving clinical outcome, often requiring the use of broad-spectrum combinations. The optimal use of antimicrobials is part of current implementation programs aimed to reduce the administration of not-necessary antibiotics, the bio-ecologic pressure and the possible side effects . In this context the application of rapid, molecular microbiological tests on respiratory samples is of overwhelming interest, due to the potential of reducing the time to inappropriate antibiotic therapy and of prompting de-escalation. During last years a new Multiplex PCR Assay for pneumonia diagnosis (Film-Array Pneumonia Panel Plus, BioFire, Salt Lake City, UT, USA) has been implementing in the clinical practice, showing very high rates of negative and positive predictive values. The hypothesis is that molecular test on lower respiratory tract samples may reduce the time to microbiological diagnosis, thus allowing early antibiotic de-escalation. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05952648
Study type Interventional
Source Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Contact Gennaro De Pascale, MD
Phone +393208998173
Email gennaro.depascale@policlinicogemelli.it
Status Recruiting
Phase N/A
Start date April 3, 2024
Completion date April 1, 2025

See also
  Status Clinical Trial Phase
Completed NCT05575050 - Impact of Teeth Brushing in Ventilated COVID-19 Patients. N/A
Not yet recruiting NCT06035796 - Performance Study of Targeted Sequencing Technology for VAP
Not yet recruiting NCT06073834 - LUNG INFECTION IN ICU (LUNG-I3)
Not yet recruiting NCT06045429 - Oral Care With 3% Hydrogen Peroxide (Oroxid®) in ICU - Effects on the Lower Airway Microbial Colonisation Phase 4
Not yet recruiting NCT06410664 - Efficiency and Safety of the Prolonged Use of Heat and Moisture Exchangers in ICU N/A
Not yet recruiting NCT04955821 - Early Identification of Pathogens in Children With Respiratory Tract Infection by Mechanical Ventilation Using mNGS
Completed NCT04038814 - The Effectiveness of the Modified Bundle in the Prevention of VAP.
Completed NCT05230472 - Effect of Statin Therapy on Mortality in Patients With Ventilator Associated Pneumonia Phase 4
Not yet recruiting NCT05738928 - Microbiological Profile of VAP Patients in Respiratory ICU
Completed NCT05176353 - Ventilator-associated Pneumonia (VAP) Diagnostic Stewardship Trial N/A